Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

A novel anti-CCN1 monoclonal antibody suppresses Rac-dependent cytoskeletal reorganization and migratory activities in breast cancer cells.

Jim Leu SJ, Sung JS, Huang ML, Chen MY, Tsai TW.

Biochem Biophys Res Commun. 2013 May 17;434(4):885-91. doi: 10.1016/j.bbrc.2013.04.045. Epub 2013 Apr 22.

PMID:
23618859
2.

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.

Lin J, Huo R, Wang L, Zhou Z, Sun Y, Shen B, Wang R, Li N.

Cancer Immunol Immunother. 2012 May;61(5):677-87. doi: 10.1007/s00262-011-1135-y. Epub 2011 Nov 3.

PMID:
22048717
3.

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.

Ceran C, Cokol M, Cingoz S, Tasan I, Ozturk M, Yagci T.

BMC Cancer. 2012 Oct 4;12:450. doi: 10.1186/1471-2407-12-450.

4.

Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells.

Cárcamo C, Pardo E, Oyanadel C, Bravo-Zehnder M, Bull P, Cáceres M, Martínez J, Massardo L, Jacobelli S, González A, Soza A.

Exp Cell Res. 2006 Feb 15;312(4):374-86.

PMID:
16368432
5.

Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.

Dokmanovic M, Hirsch DS, Shen Y, Wu WJ.

Mol Cancer Ther. 2009 Jun;8(6):1557-69. doi: 10.1158/1535-7163.MCT-09-0140. Epub 2009 Jun 9.

6.
7.

Functional interaction between E-cadherin and alphav-containing integrins in carcinoma cells.

von Schlippe M, Marshall JF, Perry P, Stone M, Zhu AJ, Hart IR.

J Cell Sci. 2000 Feb;113 ( Pt 3):425-37.

8.

CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin αv β3 and AMPK.

Park YS, Hwang S, Jin YM, Yu Y, Jung SA, Jung SC, Ryu KH, Kim HS, Jo I.

J Cell Physiol. 2015 Jan;230(1):140-9. doi: 10.1002/jcp.24690.

PMID:
24909560
9.

Adhesion and migration of extracellular matrix-stimulated breast cancer.

Bartsch JE, Staren ED, Appert HE.

J Surg Res. 2003 Mar;110(1):287-94.

PMID:
12697413
10.

A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.

Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E.

J Biol Chem. 2008 Jan 25;283(4):2031-41. Epub 2007 Dec 5.

11.

CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.

Chen Q, Manning CD, Millar H, McCabe FL, Ferrante C, Sharp C, Shahied-Arruda L, Doshi P, Nakada MT, Anderson GM.

Clin Exp Metastasis. 2008;25(2):139-48. Epub 2007 Dec 5.

PMID:
18064530
12.

Functional domains of CCN1 (Cyr61) regulate breast cancer progression.

O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang HJ, Said J, Gui D, Miller CW, Karlan BY, Koeffler HP.

Int J Oncol. 2008 Jul;33(1):59-67.

PMID:
18575751
13.

Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ.

Cancer Biol Ther. 2003 Jul-Aug;2(4):398-403.

PMID:
14508113
14.
15.

Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration.

Mijatovic T, Gailly P, Mathieu V, De Nève N, Yeaton P, Kiss R, Decaestecker C.

Cell Oncol. 2007;29(4):315-26.

16.

The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53/p21 pathway.

Jim Leu SJ, Sung JS, Chen MY, Chen CW, Cheng JY, Wang TY, Wang JJ.

J Cell Biochem. 2013 Sep;114(9):2082-93. doi: 10.1002/jcb.24557.

PMID:
23553737
18.

MEK/ERK regulates adherens junctions and migration through Rac1.

Ray RM, Vaidya RJ, Johnson LR.

Cell Motil Cytoskeleton. 2007 Mar;64(3):143-56.

PMID:
17183546
19.

The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.

Paradiso A, Cardone RA, Bellizzi A, Bagorda A, Guerra L, Tommasino M, Casavola V, Reshkin SJ.

Breast Cancer Res. 2004;6(6):R616-28. Epub 2004 Sep 13.

20.

Supplemental Content

Support Center